COVID-19 Clinical Neuroscience Study (COVID-CNS)
Addressing the urgent need to understand the biological causes of neurological and neuropsychiatric complications in hospitalised COVID-19 patients.
Tel: 0207 848 7297
Email: covidcns@kcl.ac.uk
About the study
The COVID-19 Clinical Neuroscience Study (COVID-CNS) is a £2.3m UKRI study jointly led by researchers at the University of Liverpool and King's College London. Acute neurological and neuropsychiatric complications of COVID-19 affect up to 20-30% of hospitalised patients. In collaboration with CoroNerve and ISARIC-4C study, we will identify these patients, and those that have received the COVID-19 vaccination, and invite them to join COVID-CNS, part of the COVID-19 section of the NIHR BioResource.
- Materials discovery
- Particle physics
- Therapeutics innovation
- Interdisciplinary Centre for Sustainability Research
Discover research at Liverpool:
Funders and collaborators
Watch the COVID-CNS team discuss the study
The study looks to investigate what is driving brain complications in patients with COVID-19 and why do some people develop neurological or neuropsychiatric symptoms whilst others do not.
https://youtu.be/L8k6YelXo6w
Webinar
Watch the COVID-CNS team talk about brain complications related to COVID-19 and their findings from the study, one year on from completing recruitment.
Publications
Publications
The COVID-CNS team are actively producing papers for journals with impact; take a look at the most recent articles.
Patient and public involvement
Patient and Public Involvement (PPI)
Our PPI panel are helping to shape our research study by sharing the patient’s perspective on COVID-CNS. Find out more from the PPI team.